Global Blood Therapeutics, Inc.
Global Blood Therapeutics, Inc. (GBT) is a publicly traded company in the Unknown sector. Across all available filings, 33 corporate insiders have executed 690 transactions totaling $151.1M, demonstrating a bearish sentiment with -$132.4M in net insider flow. The most recent transaction on Oct 5, 2022 involved a transaction of 43,077 shares valued at $0.
GBT Insider Activity Summary
Who Is Buying GBT Stock?
No significant insider buying has been recorded for GBT in the recent period.
Who Is Selling GBT Stock?
No significant insider selling has been recorded for GBT in the recent period.
Is Global Blood Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for GBT is bearish with an Insider Alignment Score of 6/100 and a net flow of -$132.4M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
GBT Frequently Asked Questions
Understanding GBT Insider Activity
Insider trading at Global Blood Therapeutics, Inc. (GBT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 33 insiders are actively trading GBT stock, having executed 690 transactions in the past 90 days. The most active insider is Gp Iii, Llc Trv (Executive), who has made 5 transactions totaling $52.2M.
Related Tools
Track Global Blood Therapeutics, Inc. Insider Activity
Get notified when executives and directors at GBT file new Form 4 transactions